About Betta Pharmaceuticals
Betta Pharmaceuticals is a publicly listed company based in Hangzhou (China) founded in 2003. Therapeutics for treating cancer are developed by the company. The company has 1,700 employees. Its chief executive, as recorded, is Lieming Ding. Its website bettapharma.com draws about 12 thousand monthly visits. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its legal entity is Betta Press.
Company details
Founded in 2003 and based in Hangzhou, China, operations focus on the pharmaceutical sector with an emphasis on oncology. Therapeutics targeting cancer are advanced through a pipeline that includes three programs in late-stage clinical development. The lead product, icotinib (Conmana), is utilized as a targeted therapy for non-small cell lung cancer in patients with EGFR mutations.
- Headquarters Hangzhou, China
- Employees 1,700
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website bettapharma.com
- Legal Name Betta Pharmaceuticals Co., Ltd. Class A
- Annual Revenue$514.21 M (USD)24.7as on Dec 31, 2025
- Net Profit$43.61 M (USD)-24.15as on Dec 31, 2025
- EBITDA$155.69 M (USD)28.61as on Dec 31, 2025
- Investors
- Employee Count1,700
Funding Insights of Betta Pharmaceuticals
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Betta Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2010 | Series A | – | – |
1 investors in total: 1 institutional.
Investors in Betta Pharmaceuticals
Betta Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lilly Asia Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| lillyasiaventures.com |
Investor details for Betta Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Betta Pharmaceuticals
1 people are tracked at Betta Pharmaceuticals (1 in leadership); the tracked headcount is 1,700.
| Name | Role | Group |
|---|---|---|
Lieming Ding | CEO | Leadership |
Complete people profiles for Betta Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Betta Pharmaceuticals
Betta Pharmaceuticals is a publicly listed company on the SZSE with ticker symbol 300558 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Nov 2016
- Listed onBSE: 300558
- Listed entityBetta Pharmaceuticals Co., Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE100002DD9
- Share price43.22 CNY (-4.1% on the day) · 2026-10-14
- Market capitalisation19,131,494,587.00 CNY
- Price to earnings39.0
- EPS (diluted, trailing year)1.11 CNY
- Dividend yield0.33%
- Volume (last session)12,294,724
Financials of Betta Pharmaceuticals
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 3.60B CNY | 305.3M CNY | 1.09B CNY |
| 2024 | 2.88B CNY | 402.6M CNY | 848.0M CNY |
| 2023 | 2.45B CNY | 348.0M CNY | 583.1M CNY |
| 2022 | 2.36B CNY | 145.4M CNY | 411.7M CNY |
| 2021 | 2.23B CNY | 383.1M CNY | 530.8M CNY |
Detailed financial statements for Betta Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Betta Pharmaceuticals
3 dated milestones of Betta Pharmaceuticals across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Betta Pharmaceuticals is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
Web traffic of Betta Pharmaceuticals
The website of Betta Pharmaceuticals (bettapharma.com) receives about 12.2K visits a month and ranks #1,008,300 among all websites worldwide, #1,236 in Biotechnology and Pharmaceuticals.
- Monthly visits12.2K
▼ 38.1% vs previous month
- Unique visitors2.5K
per month
- Global rank#1,008,300
among all websites
- Category rank#1,236
Health · Biotechnology and Pharmaceuticals
- Bounce rate14%
- Pages per visit7.5
- Average visit6 min 00 sec
- DevicesDesktop 66% · Mobile 34%
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Betta Pharmaceuticals
Complete news archive for Betta Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Betta Pharmaceuticals
Betta Pharmaceuticals was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Betta Pharmaceuticals is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.
Lieming Ding is the CEO of Betta Pharmaceuticals, as recorded in our data.
Betta Pharmaceuticals has 1,700 employees.
Annual revenue of Betta Pharmaceuticals is $514.21M as on Dec 31, 2025.
Founded in 2003 and based in Hangzhou, China, operations focus on the pharmaceutical sector with an emphasis on oncology. Therapeutics targeting cancer are advanced through a pipeline that includes three programs in late-stage clinical development. The lead product, icotinib (Conmana), is utilized as a targeted therapy for non-small cell lung cancer in patients with EGFR mutations.
Yes, Betta Pharmaceuticals is publicly traded on SZSE under the ticker symbol 300558.
Betta Pharmaceuticals has 1 investor. Key investors include Lilly Asia Ventures.
Betta Pharmaceuticals operates through Betta Press.